Аспекты патогенеза и особенности клинического течения эректильной дисфункции у больных с метаболическим синдромом
Аспекты патогенеза и особенности клинического течения эректильной дисфункции у больных с метаболическим синдромом
Мазо Е.Б., Гамидов С.И., Гасанов Р.В. Аспекты патогенеза и особенности клинического течения эректильной дисфункции у больных с метаболическим синдромом. Consilium Medicum. 2008; 10 (2): 62–65.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study.
J Urol 1994; 151: 151–4.
2. Nicolosi A, Moreira ED Jr, Shirai M et al. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–6.
3. NIH Consensus development conference statement. NIH consensus development panel on impotence. Int J Impot Res 1993; 4: 181–284.
4. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
5. Parazzini F, Menchini FF, Bortolotti A et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–9.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
7. Gunduz MI, Gumus BH, Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 2004; 6(4): 355–8.
8. Esposito K, Giugliano F, Martedi E et al. High proportions of erectile dysfunction in men with the metabolic syndrome, Diabetes Care 2005; 28(5): 1201–3.
9. Demir T, Demir O, Kefi A et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 2006; 13(4): 385–58.
J Urol 1994; 151: 151–4.
2. Nicolosi A, Moreira ED Jr, Shirai M et al. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–6.
3. NIH Consensus development conference statement. NIH consensus development panel on impotence. Int J Impot Res 1993; 4: 181–284.
4. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
5. Parazzini F, Menchini FF, Bortolotti A et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–9.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
7. Gunduz MI, Gumus BH, Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 2004; 6(4): 355–8.
8. Esposito K, Giugliano F, Martedi E et al. High proportions of erectile dysfunction in men with the metabolic syndrome, Diabetes Care 2005; 28(5): 1201–3.
9. Demir T, Demir O, Kefi A et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 2006; 13(4): 385–58.
Авторы
Е.Б.Мазо, С.И.Гамидов, Р.В.Гасанов
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.